"The leading multi-profile medical-diagnostic institution in Caucasus region, which is equipped with the newest medical equipment in the world. The hospital has started functioning in 2007 and today, it unites 12 branches and 19 laboratories throughout Georgia."

During the past decade, LTD Aversi Clinic conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 11 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 9 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LTD Aversi Clinic" #1 sponsor was "Celgene" with 6 trials, followed by "H. Lundbeck A/S" with 6 trials sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LTD Aversi Clinic" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "LTD Aversi Clinic" are "Ulcerative Colitis" (6 trials), "Migraine" (5 trials), "Multiple Sclerosis" (4 trials), "Crohn Disease" (3 trials) and "Chronic Rhinosinusitis" (2 trials). Many other conditions were trialed in "LTD Aversi Clinic" in a lesser frequency.

Most popular intervention types in "LTD Aversi Clinic" are "Drug" (33 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Eptinezumab" (5 trials), "Etrasimod" (5 trials), "Ozanimod" (4 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "LTD Aversi Clinic" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "LTD Aversi Clinic". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in LTD Aversi Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LTD Aversi Clinic, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".